Foundation Fighting Blindness Retinal Degeneration Fund

Foundation Fighting Blindness Retinal Degeneration Fund is listed in filings as Director, otherSee Remarks, 10% Owner at Opus Genetics, Inc.. This profile follows SEC Form 4 activity through May 20, 2026, including sale activity. Recent filings connect the profile to Opus Genetics, Inc. (IRD). The current snapshot covers public activity from May 6, 2025 to May 20, 2026. Reported amounts are shown as $8.6M to $7.4M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.